Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$587.2M
35M shares
52-week range
$15.42 – $19.71
35% from low
Sector
STATE COMMERCIAL BANKS
Exchange
NYSE
CS
P/S (TTM)
1.3
EV / FCF (TTM)
17.1
Northpointe Bancshares Inc is a bank holding company focused on mortgage portfolio lender. The bank also offers a nationwide mortgage purchase program, residential mortgage lending, digital deposit banking to retail customers and custodial deposit services to loan servicing clients. It offers financial products and services through two business segments, Mortgage Purchase Program provides independent mortgage banking platforms nationwide with an alternative to traditional mortgage warehouse lending; and Retail Banking provides a vast array of financial products and services to consumers nationwide which include residential mortgages, AIO Loans, other consumer loans, and loan servicing, as well as various types of deposit products, including checking, savings and time deposit accounts.
www.northpointe.comNo one on the platform currently holds NPB.
No tracked institution reports a position in NPB as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-15 | $0.0250 | 2026-08-04 |
| 2026-04-15 | $0.0250 | 2026-05-05 |
| 2026-01-15 | $0.0250 | 2026-02-03 |
| 2025-10-15 | $0.0250 | 2025-11-03 |
| 2025-07-15 | $0.0250 | 2025-08-04 |
| 2025-04-15 | $0.0250 | 2025-05-02 |
No one on the platform has traded NPB yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 5.2% | — | — | — | ||
| Rev. Growth % | 20.7% | 67.1% | ||||
| Profit Margin % | 17.7% | -520.1% | ||||
| Free Cash Flow Margin % | 8.8% | -1438.2% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is -13.2% on the P/E track.
At today's price, your expected annual return is -9.4% on the P/E track.
At today's price, your expected annual return is -5.5% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $258M | +7.7% | $2.47 | $2.45–$2.49 | 6.8× | 2 |
| 2027 | $282M | +9.3% | $2.74 | $2.64–$2.83 | 6.2× | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-21 | $0.68 | $0.60 | -11.4% |
| 2026-04-21 | $0.63 | $0.62 | -0.8% |
| 2026-01-20 | $0.60 | $0.52 | -13.3% |
| 2025-10-21 | $0.56 | $0.57 | +1.8% |
| 2025-07-22 | $0.51 | $0.51 | +0.0% |
| 2025-04-22 | $0.48 | $0.49 | +2.1% |
| 2025-03-31 | $-0.01 | $-0.01 | +0.0% |
| 2024-11-14 | $-0.16 | $-0.25 | -56.3% |
| $1.3B |
| — |
| ERASErasca, Inc. | $16.25 | +0.56% | $5.6B | — |
| LEGNLegend Biotech Corporation | $17.67 | -4.64% | $3.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.